Related Experiment Videos
A case of generalized Wegener's granulomatosis in childhood: successful therapy with cyclophosphamide
Insights
Wegener's granulomatosis in children is rare but treatable. Cyclophosphamide therapy induced remission in an 11-year-old boy, highlighting its effectiveness for this vasculitis.
Area of Science:
- Pediatric Rheumatology
- Nephrology
- Immunology
Background:
- Wegener's granulomatosis (WG) is a rare systemic vasculitis affecting children.
- WG presents with diverse symptoms, including upper respiratory, pulmonary, and renal involvement.
Observation:
- An 11-year-old boy presented with symptoms consistent with WG.
- Clinical and pathological findings confirmed the diagnosis of generalized WG.
Findings:
- Treatment with cyclophosphamide resulted in complete remission.
- Both clinical and pathological criteria confirmed disease remission.
- Renal biopsy was crucial for diagnosis and guiding treatment.
Implications:
- Early diagnosis and intervention with cytotoxic agents like cyclophosphamide can significantly alter the disease course in pediatric WG.
- Monitoring via renal biopsies aids in treatment decisions.
- WG should be considered in children with unexplained respiratory, pulmonary, and renal issues.
Abstract:
An 11-year-old white boy had Wegener's granulomatosis, a rare condition in the pediatric age group. The clinical course, pathological findings, and mode of treatment are outlined. The disease is in remission on a regimen of cyclophosphamide therapy as judged by both clinical and pathological criteria. This syndrome with protein manifestations should be considered in children with symptoms of repeated upper respiratory tract infections along with pulmonary and renal involvement. Early renal biopsy helps to establish the diagnosis of generalized involvement and to guide the course of treatment. Follow-up renal biopsies may serve as an indication for the continuation of treatment. Cytotoxic agents, especially cyclophosphamide, dramatically alter the course of the disease.